Sunitinib versus dacarbazine as first-line treatment in patients with metastatic uveal melanoma

被引：0
|
作者：
Sacco, Joseph J.
Nathan, Paul D.
Danson, Sarah
Lorigan, Paul
Nicholson, Steve
Ottensmeier, Christian
Corrie, Philippa
Steven, Neil
Goodman, Andrew
Larkin, James M. G.
Evans, T. R. Jeffry
Kumar, Satish
Coupland, Sarah E.
Silcocks, Paul
Marshall, Ernie
机构：
[1] Clatterbridge Canc Ctr, Clatterbridge, Merseyside, England
[2] Mt Vernon Canc Ctr, Northwood, Middx, England
[3] Weston Pk Hosp, Canc Res Ctr, Sheffield, S Yorkshire, England
[4] Christie Hosp NHS Fdn Trust, Manchester, Lancs, England
[5] Charing Cross Hosp, London, England
[6] Southampton Univ Hosp NHS Fdn Trust, Southampton, Hants, England
[7] Addenbrookes Hosp, Ctr Oncol, Cambridge, England
[8] Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England
[9] Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England
[10] Royal Marsden Hosp NHS Fdn Trust, London, England
[11] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[12] Velindre Canc Ctr, Cardiff, S Glam, Wales
[13] Univ Liverpool, Dept Mol & Clin Canc Med, Inst Translat Med, Liverpool L69 3BX, Merseyside, England
[14] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9031
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A randomized phase II study of sunitinib versus dacarbazine in the treatment of patients with metastatic uveal melanoma.
    Marshall, Ernest
    Coupland, Sarah
    Corrie, Philippa
    Damato, Bertil
    Danson, Sarah
    Dobson, Lisa
    Evans, T. R. Jeffry
    Goodman, Andrew
    Kalirai, Helen
    Jones, Sarah
    Kumar, Satish
    Larkin, James M. G.
    Lorigan, Paul
    Nicholson, Steve
    Ottensmeier, Christian
    Silcocks, Paul
    Steven, Neil
    Tudur-Smith, Catrin
    Nathan, Paul D.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Pembrolizumab as first-line treatment for metastatic uveal melanoma
    Ernesto Rossi
    Monica Maria Pagliara
    Daniela Orteschi
    Tommaso Dosa
    Maria Grazia Sammarco
    Carmela Grazia Caputo
    Gianluigi Petrone
    Guido Rindi
    Marcella Zollino
    Maria Antonietta Blasi
    Alessandra Cassano
    Emilio Bria
    Giampaolo Tortora
    Giovanni Schinzari
    Cancer Immunology, Immunotherapy, 2019, 68 : 1179 - 1185
  • [3] Pembrolizumab as first-line treatment for metastatic uveal melanoma
    Rossi, Ernesto
    Pagliara, Monica Maria
    Orteschi, Daniela
    Dosa, Tommaso
    Sammarco, Maria Grazia
    Caputo, Carmela Grazia
    Petrone, Gianluigi
    Rindi, Guido
    Zollino, Marcella
    Blasi, Maria Antonietta
    Cassano, Alessandra
    Bria, Emilio
    Tortora, Giampaolo
    Schinzari, Giovanni
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (07) : 1179 - 1185
  • [4] Lenvatinib combined with dacarbazine versus dacarbazine alone as first-line treatment in patients with stage IV melanoma
    Maio, Michele
    Hassel, Jessica Cecile
    Del Vecchio, Michele
    Testori, Alessandro
    Ascierto, Paolo Antonio
    Marshall, Ernie
    Glen, Hiliary
    Lorigan, Paul
    Meek, Elaine
    Liou, Song
    Hodge, Jeff Paul
    Bologna, Fabrina
    Dave, Harish P.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Dacarbazine as First Line Treatment of Metastatic Melanoma in Elderly Patients
    Carneiro, F.
    Godinho, J.
    Sousa, N.
    Ferreira, P.
    Raimundo, A.
    Rodrigues, H.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S279 - S280
  • [6] A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma
    O'Neill, Penny A.
    Butt, Mohammad
    Eswar, Chinnamani V.
    Gillis, Pat
    Marshall, Ernest
    MELANOMA RESEARCH, 2006, 16 (03) : 245 - 248
  • [7] Phase II Trial of Bevacizumab in Combination With Temozolomide as First-Line Treatment in Patients With Metastatic Uveal Melanoma
    Piperno-Neumann, Sophie
    Diallo, Alhassane
    Etienne-Grimaldi, Marie-Christine
    Bidard, Francois-Clement
    Rodrigues, Manuel
    Plancher, Corine
    Mariani, Pascale
    Cassoux, Nathalie
    Decaudin, Didier
    Asselain, Bernard
    Servois, Vincent
    ONCOLOGIST, 2016, 21 (03): : 281 - 282
  • [8] First-Line Selective Internal Radiation Therapy in Patients with Uveal Melanoma Metastatic to the Liver
    Ponti, Alexandre
    Denys, Alban
    Digklia, Antonia
    Schaefer, Niklaus
    Hocquelet, Arnaud
    Knebel, Jean-Francois
    Michielin, Olivier
    Dromain, Clarisse
    Duran, Rafael
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (03) : 350 - 356
  • [9] COMPARATIVE EFFICACY OF SUNITINIB VERSUS SORAFENIB AS THE FIRST-LINE TREATMENT FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
    Park, S. J.
    Lee, J.
    Park, I.
    Park, K.
    Ahn, J.
    Lee, D. H.
    Song, C.
    Hong, J. H.
    Kim, C.
    Ahn, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 287 - 288
  • [10] Comparative Efficacy of Sunitinib versus Sorafenib as First-Line Treatment for Patients with Metastatic Renal Cell Carcinoma
    Park, Seong Joon
    Lee, Jae-Lyun
    Park, Inkeun
    Park, Kwonoh
    Ahn, Yongcheol
    Ahn, Jin-Hee
    Lee, Dae-Ho
    Ahn, Shin
    Song, Cheryn
    Hong, Jun Hyuk
    Kim, Choung-Soo
    Ahn, Hanjong
    CHEMOTHERAPY, 2012, 58 (06) : 468 - 474
12345